Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058051HIVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057150HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057354HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20040604HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS44006680HTLV-1ENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TCGA Plot Options
Drug Information
GeneDRD3
DrugBank IDDB00714
Drug NameApomorphine
Target IDBE0000581
UniProt IDP35462
Regulation Typeagonist
PubMed IDs11752352; 15037665
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@LeWitt PA: Subcutaneously administered apomorphine: pharmacokinetics and metabolism. Neurology. 2004 Mar 23;62(6 Suppl 4):S8-11. doi: 10.1212/wnl.62.6_suppl_4.s8.
GroupsApproved; Investigational
Direct ClassificationAporphines
SMILES[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Pathways
PharmGKBPA164781163
ChEMBLCHEMBL53